In recent years, the rapid rise of blockchain technology and the promise of tokenized assets have captured the imagination of investors, fintech innovators, and regulators alike. Among the most talked‑about concepts is the idea of synthetic tokenized stocks—digital representations of equity that exist on a blockchain but are not backed by the actual underlying shares. While proponents argue that these instruments democratize access to global equities and increase market efficiency, a growing chorus of experts warns that synthetic tokenized stocks pose serious risks to American investors and undermine the very foundations of the United States capital markets.

At the heart of the issue is the principle of ownership. In traditional U.S.

markets, when an investor purchases a share of a publicly traded company, the investor receives a legally enforceable claim to that share. This claim is recorded in the name of the investor (or their broker) on the books of the issuing company’s transfer agent, and it carries with it a bundle of rights: voting at shareholder meetings, entitlement to dividends, and the ability to sell the share on an exchange.

This framework has been built over decades of regulatory oversight, legal precedent, and market practice, creating a high degree of trust among participants. Synthetic tokenized stocks, by contrast, are not actual shares. They are contractual promises, often issued by third‑party platforms, that aim to mirror the price movements of a real stock.

The token holder typically does not have any direct claim on the underlying equity, nor does the token confer voting rights or dividend entitlements. Instead, the token’s value is derived from a set of smart contracts or an off‑chain ledger that tracks the price of the referenced stock.

In many cases, the platform issuing the token must maintain a reserve of the actual shares or a cash collateral to back each token, but this arrangement is opaque, lightly regulated, and prone to failure. Aaron Kaplan, founder of the fintech firm Promethum, emphasizes that this synthetic model “cheapens” the trust that investors place in U.S.

markets. Trust is not a trivial commodity; it is the engine that drives liquidity, price discovery, and the willingness of individuals and institutions to allocate capital. When investors are told that a token represents a share, but the token is only a promise that could be broken, the credibility of the entire market ecosystem erodes. The result is a two‑tier system where traditional shareholders retain full legal rights, while token holders are left with a precarious, contractual claim that may be subject to the platform’s solvency, technical glitches, or regulatory crackdowns.

The potential for short‑changing U.S. investors is significant.

First, there is counterparty risk. If the platform that issues synthetic tokens experiences financial distress, loses its reserve of underlying shares, or simply decides to halt trading, token holders may find their assets rendered worthless, despite the fact that the real shares continue to trade on established exchanges.

Unlike a brokerage account that is protected by SIPC insurance up to certain limits, many token platforms operate outside the protective umbrella of U.S. securities law, leaving investors exposed. Second, synthetic tokens can create price distortion.

Because the tokens are not bound by the same settlement and clearing mechanisms as traditional securities, they can be traded 24/7 on unregulated venues, potentially leading to price discrepancies between the token and the underlying stock. Arbitrageurs may exploit these gaps, but retail investors—who are often the most vulnerable—may suffer from sudden, unexplained price swings. Moreover, the lack of transparent reporting on the reserve holdings makes it difficult for investors to verify whether each token is truly backed, further amplifying uncertainty. Third, the issuance of synthetic tokenized stocks undermines the issuer‑led capital markets model that has historically funded American innovation.

Companies raise capital by issuing shares directly to investors, who receive a proportional stake in the company’s future earnings and governance. This direct relationship aligns incentives: shareholders benefit when the company succeeds, and the company is motivated to act in shareholders’ best interests. When third‑party platforms create synthetic replicas of those shares, they effectively decouple the capital‑raising process from the investor base, allowing speculative trading that does not contribute to the company’s growth. In the long run, this could diminish the willingness of firms to list on U.S.

exchanges, weakening the nation’s position as a global capital hub. Regulators are beginning to take notice.

The Securities and Exchange Commission (SEC) has issued guidance indicating that many tokenized securities, including synthetic tokens that track real equities, fall within the definition of “security” and therefore must comply with registration, disclosure, and anti‑fraud provisions. However, enforcement is challenging because many platforms operate offshore or claim to be merely providing “utility tokens” rather than securities. The regulatory gray area creates a fertile ground for fraud, as bad actors can market synthetic tokens with minimal oversight, promising high returns while concealing the lack of underlying assets.

For American investors, the prudent approach is to treat synthetic tokenized stocks with the same caution one would apply to any unregistered security. Conduct thorough due diligence, verify that the issuing platform maintains a transparent, auditable reserve of the actual shares, and understand that the token does not confer the same legal rights as a traditional share. Investors should also be aware that, unlike a broker‑dealer, many token platforms do not offer the same level of customer protection, dispute resolution, or recourse in the event of loss. In conclusion, while the allure of blockchain‑based financial products is undeniable, synthetic tokenized stocks represent a departure from the trusted, issuer‑centric model that has made U.S.

markets the gold standard worldwide. By diluting the certainty of ownership, introducing heightened counterparty risk, and potentially destabilizing price discovery, these synthetic instruments threaten to short‑change American investors and erode confidence in the capital markets. Until clear regulatory frameworks are established and robust safeguards are put in place, investors would be wise to approach synthetic tokenized stocks with skepticism and prioritize traditional, fully backed equities for their portfolios.